Project Grant R21EB036776
Award Date 8/1/25
Completion Date 7/31/27
Dollars Obligated $430K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Notre Dame, IN 46556, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $745,249 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Notre Dame DU Lac. The project aims to develop a once-weekly and glucose-responsive insulin formulation. The research focuses on chemically modifying insulin with a novel glucose binder and a dendrimer carrier to create a subcutaneous nanocomplex insulin depot that can...
- The University of Notre Dame received a two-year, $120,000 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program to develop next-generation, self-evolving implantable medical devices. Through the award ending April 2025, the university will research cross-layer co-design approaches allowing dynamic adjustment of detection algorithms and hardware configurations in implantable devices based on individual patient data and circumstances. The goal is to...
- The University of Notre Dame DU Lac received a $402,404 Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to develop a scalable, continuous production platform for manufacturing therapeutic exosomes. The project aims to address key challenges in exosome-based drug delivery by: Developing a high-throughput exosome production bioreactor module using a 3D piezoelectric scaffold to stimulate exosome secretion. Creating a high-efficiency...
- This Project Grant award of $939,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports research conducted by the University of Notre Dame's Notre Dame Research Division, known as the Office of Research, focused on analyzing the relationship between host obesity and therapeutic response in ovarian cancer. The project aims to advance understanding and treatment of this disease, with an...
- This $622,340 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the University of Notre Dame to develop multispecific bridge nanoparticles. The goal is to engage T cells and off-the-shelf CAR-T cells against antigen-positive endothelial cell (EC) tumors, with the aim of enhancing antitumor immune activity. The award period runs from June 1, 2025 to May 31, 2027. This grant demonstrates the...
- The University of Notre Dame received a $250,000 project grant award from the National Science Foundation Division of Industrial Innovation. The award is part of the NSF Engineering program (CFDA 47.041) to support the development of 5-minute protein analyses from September 1, 2021 through February 28, 2023. The grant funding will allow the University to develop new techniques for rapidly analyzing protein compositions, with the goal of improving industrial biomanufacturing processes. The...
- The University of Notre Dame DU Lac's Notre Dame Research Division, doing business as the Office of Research, received a $471,006.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The 3-year grant, awarded on September 15, 2023, supports a bench-bedside-bidirectional investigation of a new combinatorial immunotherapy strategy to treat platinum-resistant penile cancer. As a leading research university, the University...
- The University of Notre Dame received a $491,300 Project Grant award from the National Science Foundation Division of Chemistry on September 1, 2021 to support research titled "SELF-IMMOLATIVE BOLAAMPHIPHILES FOR SIGNAL TRANSDUCTION ACROSS BILAYER MEMBRANES." The award will fund research through August 31, 2024 under the NSF's Mathematical and Physical Sciences program (CFDA 47.049), which aims to promote progress in these scientific fields and strengthen the national scientific...
- The University of Notre Dame received a $460,000 project grant award from the National Science Foundation Division of Chemistry on July 1, 2021 for research concluding on June 30, 2024. The award is part of the NSF's Mathematical and Physical Sciences program (CFDA 47.049), which aims to advance scientific knowledge and understanding of major issues. Specifically, the funding will support the University's "BACKBONE N-HETEROATOM PROTEIN ORTHOTICS" research project. While further details...
- This $335,410 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports the development of a needle-free microneedle array patch (MAP) for delivering a GLP-1 receptor agonist to treat type 2 diabetes. The grant recipient, Vaxess Technologies, Inc., is a biotechnology company specializing in innovative MAP technologies for drug and vaccine...
The University of Notre Dame was awarded a $430,375 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286) to develop innovative, long-lasting depots for delivering glucagon-like peptide 1 receptor agonists (GLP1-RAs) to treat diabetes and obesity. The project aims to engineer GLP1-RA therapies that can provide multi-month duration of therapeutic function through the use of self-assembling nanofibrillar systems. This research seeks to create GLP1-RA formulations that can reduce side effects and improve patient adherence compared to existing once-weekly injectable treatments. The grant period runs from August 1, 2025 through July 31, 2027.
Generated 10/21/25, 4:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $430.4k | 7/30/25 |